Sahinoglu Melek, Sargin Gokhan, Yavasoglu Irfan, Senturk Taskin
Department of Internal Medicine, Aydin Adnan Menderes University, Aydin, Turkey.
Department of Rheumatology, Aydin Adnan Menderes University, Aydin, Turkey.
Clin Exp Med. 2024 Jan 27;24(1):19. doi: 10.1007/s10238-023-01286-9.
We aimed to investigate the association between follicular T helper cells (Tfh) and disease severity in systemic sclerosis (SSc), a chronic connective tissue disease characterized by progressive fibrosis. While Tfh cells have been extensively studied in other autoimmune diseases, their role in SSc remains poorly understood. A cohort of 50 SSc patients, diagnosed based on the ACR/EULAR 2013 classification criteria, was included in the study. Patient data, including demographic information, comorbidities, treatment history and organ involvement, were collected. Disease severity was assessed using the modified Rodnan skin score and Medsger disease severity index. Statistical analyses were performed, considering a p value of < 0.05 as statistically significant. 38% had SSc with limited skin involvement, while 62% had SSc with extensive skin involvement. However, there were no statistically significant differences observed in the levels of CD4+ CXCR5+ , CD4+ ICOS+ , CD4+ CD40L+ and CD4+ PD+ lymphocytes between the two groups. Notably, SSc patients with Raynaud's phenomenon, digital ulcer and lung involvement exhibited higher levels of CD4+ CXCR5+ lymphocytes compared to those without these manifestations. Furthermore, a significant positive correlation was observed between CD4+ CXCR5+ lymphocyte levels and the severity of lung disease according to the Medsger disease severity index. Based on these findings, we conclude that elevated levels of Tfh cells are associated with lung involvement in SSc and there is a significant correlation between Tfh cell levels and the severity of lung disease. These observations suggest a potential role for Tfh cells in the pathogenesis of lung involvement in SSc and may guide the development of targeted therapies for this aspect of the disease.
我们旨在研究滤泡辅助性T细胞(Tfh)与系统性硬化症(SSc)疾病严重程度之间的关联,SSc是一种以进行性纤维化为特征的慢性结缔组织疾病。虽然Tfh细胞在其他自身免疫性疾病中已得到广泛研究,但其在SSc中的作用仍知之甚少。本研究纳入了50例根据2013年美国风湿病学会/欧洲抗风湿病联盟(ACR/EULAR)分类标准确诊的SSc患者。收集了患者数据,包括人口统计学信息、合并症、治疗史和器官受累情况。使用改良的罗德南皮肤评分和梅兹格疾病严重程度指数评估疾病严重程度。进行了统计分析,将p值<0.05视为具有统计学意义。38%的患者为皮肤受累局限型SSc,而62%的患者为皮肤受累广泛型SSc。然而,两组之间CD4+CXCR5+、CD4+ICOS+、CD4+CD40L+和CD4+PD+淋巴细胞水平未观察到统计学上的显著差异。值得注意的是,与无雷诺现象、指端溃疡和肺部受累的SSc患者相比,有这些表现的患者CD4+CXCR5+淋巴细胞水平更高。此外,根据梅兹格疾病严重程度指数,观察到CD4+CXCR5+淋巴细胞水平与肺部疾病严重程度之间存在显著正相关。基于这些发现,我们得出结论,Tfh细胞水平升高与SSc患者的肺部受累有关,且Tfh细胞水平与肺部疾病严重程度之间存在显著相关性。这些观察结果提示Tfh细胞在SSc肺部受累的发病机制中可能起作用,并可能指导针对该疾病这一方面的靶向治疗的开发。